NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance
NADPH oxidase NOX4 has been linked to poor cancer survival. Here the authors show that NOX4 regulates drug resistance in renal cancer carcinoma by regulating PKM2 and that NOX4 activity is allosterically activated by reduced mitochondrial ATP levels thus coupling energy metabolism to drug resistance...
Guardado en:
Autores principales: | Karthigayan Shanmugasundaram, Bijaya K. Nayak, William E. Friedrichs, Dharam Kaushik, Ronald Rodriguez, Karen Block |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b6112e9eaddb4fcbbe6870525a0bd64f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Glycolytic reprograming in Salmonella counters NOX2-mediated dissipation of ΔpH
por: Sangeeta Chakraborty, et al.
Publicado: (2020) -
Nox4 is a Target for Tuberin Deficiency Syndrome
por: Qian Shi, et al.
Publicado: (2018) -
Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy
por: Elizabeth D. Luczak, et al.
Publicado: (2020) -
Prediction of engine NOx for virtual sensor using deep neural network and genetic algorithm
por: Kim Jongmyung, et al.
Publicado: (2021) -
Thermodynamics of Active Field Theories: Energetic Cost of Coupling to Reservoirs
por: Tomer Markovich, et al.
Publicado: (2021)